P C Familletti

5.3k total citations · 5 hit papers
19 papers, 4.5k citations indexed

About

P C Familletti is a scholar working on Immunology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, P C Familletti has authored 19 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Immunology and Allergy. Recurrent topics in P C Familletti's work include Immune Cell Function and Interaction (5 papers), Cell Adhesion Molecules Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). P C Familletti is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cell Adhesion Molecules Research (5 papers) and Protease and Inhibitor Mechanisms (4 papers). P C Familletti collaborates with scholars based in United States, Switzerland and Germany. P C Familletti's co-authors include Sidney Pestka, A G Wolitzky, P M Quinn, Sara Rubinstein, Ueli Gubler, Y C Pan, A O Chua, Frank Podlaski, Warren McComas and David S. Schoenhaut and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

P C Familletti

19 papers receiving 4.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

1990 689 citations Matthias Clauss, Marlene L. Gerlach et al. The Journal of Experimental Medicine profile →
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells.

1990 579 citations A S Stern, Frank Podlaski et al. Proceedings of the National Academy of Sciences profile →
Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

1991 508 citations Ueli Gubler, A O Chua et al. Proceedings of the National Academy of Sciences profile →
Convenient assay for interferons

1981 428 citations Sara Rubinstein, P C Familletti et al. Journal of Virology profile →
Human leukocyte interferon produced by E. coli is biologically active

1980 413 citations David V. Goeddel, Elizabeth Yelverton et al. Nature profile →

Peers

Countries citing papers authored by P C Familletti

Since Specialization

Citations

This map shows the geographic impact of P C Familletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P C Familletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P C Familletti more than expected).

Fields of papers citing papers by P C Familletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P C Familletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P C Familletti. The network helps show where P C Familletti may publish in the future.

Co-authorship network of co-authors of P C Familletti

This figure shows the co-authorship network connecting the top 25 collaborators of P C Familletti. A scholar is included among the top collaborators of P C Familletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P C Familletti. P C Familletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival. 1994 ·The Journal of Immunology ·(unknown), J Hakimi, (unknown), Pascal Bailon, P C Familletti, (unknown), (unknown), Gary L. Parenteau, Frederick M. Dirbas, Mitsuru Tsudo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	37
2	Consensus repeat domains of E-selectin enhance ligand binding. 1994 ·Journal of Biological Chemistry ·(unknown), Daniel K. Burns, John M. Rumberger, David H. Presky, Victoria L. Wilkinson, (unknown), B A Wolitzky, Christine R. Norton, P C Familletti, (unknown)	42
3	Cloning and expression of murine IL-12 1992 ·The Journal of Immunology ·David S. Schoenhaut, A O Chua, A G Wolitzky, P M Quinn, (unknown), Warren McComas, P C Familletti, Maurice K. Gately, Ueli Gubler	417
4	Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. 1992 ·Journal of Biological Chemistry ·J Kao, J Ryan, G. M. Brett, (unknown), Haibo Shen, Yan Fan, Gabriel C. Godman, P C Familletti, (unknown), Y C Pan	162
5	Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. breakdown → 1991 ·Proceedings of the National Academy of Sciences ·Ueli Gubler, A O Chua, David S. Schoenhaut, (unknown), Warren McComas, (unknown), N Nabavi, A G Wolitzky, P M Quinn, P C Familletti	508
6	Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) 1991 ·The Journal of Immunology ·Maurice K. Gately, (unknown), A G Wolitzky, P M Quinn, (unknown), Frank Podlaski, P C Familletti, Francesco Sinigaglia, (unknown), Ueli Gubler	410
7	Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys 1991 ·The Journal of Immunology ·J Hakimi, R Chizzonite, David R. Luke, P C Familletti, Pascal Bailon, (unknown), (unknown), (unknown), (unknown), (unknown)	82
8	Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. breakdown → 1990 ·The Journal of Experimental Medicine ·Matthias Clauss, Marlene L. Gerlach, Herwig Gerlach, J Brett, F. Wang, P C Familletti, Y C Pan, Jitka V. Olander, Daniel T. Connolly, D Stern	689
9	Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. breakdown → 1990 ·Proceedings of the National Academy of Sciences ·A S Stern, Frank Podlaski, J D Hulmes, Y C Pan, P M Quinn, A G Wolitzky, P C Familletti, (unknown), Theresa Truitt, R Chizzonite	579
10	A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. 1990 ·Journal of Biological Chemistry ·Matthias Clauss, J. Clifford Murray, Mônica Ryff Moreira Roca Vianna, Rob de Waal, Gavin Thurston, Peter P. Nawroth, Herwig Gerlach, R Bach, P C Familletti, D Stern	61
11	Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction. 1987 ·Journal of Biological Chemistry ·J Hakimi, C Seals, (unknown), Frank Podlaski, (unknown), Waleed Danho, James C. Jenson, Anthony V. Perkins, (unknown), P C Familletti	44
12	Characterization of the phosphatidylinositol-glycan membrane anchor of human placental alkaline phosphatase. 1987 ·Proceedings of the National Academy of Sciences ·Andrew Howard, J Berger, Louise Gerber, P C Familletti, Sidney Udenfriend	74
13	Recombinant human interleukin 1 alpha: purification and biological characterization. 1986 ·The Journal of Immunology ·Ueli Gubler, A O Chua, A S Stern, (unknown), Michael P. Vitek, Thomas M. DeChiara, W R Benjamin, K J Collier, Mitchell Dukovich, P C Familletti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	191
14	Molecular weight of the functional unit of human leukocyte, fibroblast, and immune interferons. 1983 ·Journal of Biological Chemistry ·Sidney Pestka, Bruce Kelder, P C Familletti, John Moschera, Robert M. Crowl, E.S. Kempner	67
15	Production of high levels of human leukocyte interferon from a continuous human myeloblast cell culture 1981 ·Antimicrobial Agents and Chemotherapy ·P C Familletti, Russell McCandliss, Sidney Pestka	23
16	Convenient assay for interferons breakdown → 1981 ·Journal of Virology ·Sara Rubinstein, P C Familletti, Sidney Pestka	428
17	Human leukocyte interferon produced by E. coli is biologically active breakdown → 1980 ·Nature ·David V. Goeddel, Elizabeth Yelverton, Axel Ullrich, Herbert L. Heyneker, Giuseppe Miozzari, William E. Holmes, Peter H. Seeburg, Thomas J. Dull, Laurie May, N. Stebbing, Roberto Crea, Shuichiro Maeda, Russell McCandliss, Alan Sloma, John Tabor, Mitchell Gross, P C Familletti, Sidney Pestka	413
18	Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. 1980 ·Proceedings of the National Academy of Sciences ·Shuichiro Maeda, Russell McCandliss, Mitchell Gross, Alan Sloma, P C Familletti, John Tabor, Marian J. Evinger, Warren P. Levy, Sidney Pestka	98
19	Human leukocyte interferon: production, purification to homogeneity, and initial characterization. 1979 ·Proceedings of the National Academy of Sciences ·Menachem Rubinstein, Sara Rubinstein, P C Familletti, Robert S. Miller, Alan A. Waldman, Sidney Pestka	173

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact